Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03734042Phase 4Completed
Phase 4, randomised trial of platelet-rich plasma injection in Repeated Implantation Failure (RIF) (2 arms), sponsored by Tanta University. Primary endpoints: Endometrial thickness at 8 days and Pregnancy rate at 15 days. Started Dec 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03734042.